Nithi Mahanonda
Bangkok, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Post-exposure prophylaxis with favipiravir among household close contacts to confirmed COVID-19 cases: A cluster-randomized trial (PEPfavi).
Journal: Journal of infection and public health
Published: July 14, 2025
Assessing favipiravir impact on SARS-CoV-2 transmission within households: Insights from a multi-center study (FaviPrev).
Journal: Journal of virus eradication
Published: October 24, 2024
Exploring alternative funding mechanisms to improve patient access to innovative medicines.
Journal: BMC health services research
Published: October 15, 2024
Current German Recommendations and International Research on the Use of COVID-19 Boosters among Health Care Providers in 2024: A Narrative Review.
Journal: Medicina (Kaunas, Lithuania)
Published: February 02, 2024
Unveiling therapeutic dynamics: An in-depth comparative analysis of neutralizing monoclonal antibodies and favipiravir in alleviating COVID-19 outpatients impacts among middle-aged and special populations (MA-FAST).
Journal: Journal of infection and public health
Published: January 19, 2024
Efficacy of combined COVID-19 convalescent plasma with oral RNA-dependent RNA polymerase inhibitor treatment versus neutralizing monoclonal antibody therapy in COVID-19 outpatients: a multi-center, non-inferiority, open-label randomized controlled trial (PlasMab).
Journal: Microbiology spectrum
Published: November 17, 2023
The Real-World Clinical Outcomes of Favipiravir Treatment with Telemedicine Monitoring in Preventing Disease Progression in Mild to Moderate COVID-19 Patients; A Retrospective Cohort Study.
Journal: Medicina (Kaunas, Lithuania)
Published: May 05, 2023
The real-world effectiveness of fluvoxamine therapy in mild to moderate COVID-19 patients; A historical cohort study (Fluvoxa Trial).
Journal: Journal of infection and public health
Published: April 19, 2023
Efficacy of combination therapy of fluvoxamine and favipiravir vs favipiravir monotherapy to prevent severe COVID-19 among mild to moderate COVID-19 patients: Open-label randomized controlled trial (EFFaCo study).
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: April 03, 2023
Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial).
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 05, 2022
Protection of inactivated vaccine against SARS-CoV-2 infections in patients with comorbidities: a prospective cohort study.
Journal: Frontiers of medicine
Published: October 23, 2022
Last Updated: 09/26/2026